IT1395736B1 - Forme cristalline di rufinamide - Google Patents

Forme cristalline di rufinamide

Info

Publication number
IT1395736B1
IT1395736B1 ITMI2009A001412A ITMI20091412A IT1395736B1 IT 1395736 B1 IT1395736 B1 IT 1395736B1 IT MI2009A001412 A ITMI2009A001412 A IT MI2009A001412A IT MI20091412 A ITMI20091412 A IT MI20091412A IT 1395736 B1 IT1395736 B1 IT 1395736B1
Authority
IT
Italy
Prior art keywords
rufinamide
crystalline forms
crystalline
forms
Prior art date
Application number
ITMI2009A001412A
Other languages
English (en)
Inventor
Pietro Allegrini
Chiara Vladiskovic
Emanuele Attolino
Original Assignee
Dipharma Francis Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dipharma Francis Srl filed Critical Dipharma Francis Srl
Priority to ITMI2009A001412A priority Critical patent/IT1395736B1/it
Priority to EP10170757A priority patent/EP2292609A1/en
Priority to US12/849,069 priority patent/US20110034523A1/en
Publication of ITMI20091412A1 publication Critical patent/ITMI20091412A1/it
Application granted granted Critical
Publication of IT1395736B1 publication Critical patent/IT1395736B1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ITMI2009A001412A 2009-08-04 2009-08-04 Forme cristalline di rufinamide IT1395736B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI2009A001412A IT1395736B1 (it) 2009-08-04 2009-08-04 Forme cristalline di rufinamide
EP10170757A EP2292609A1 (en) 2009-08-04 2010-07-26 Crystalline forms of rufinamide
US12/849,069 US20110034523A1 (en) 2009-08-04 2010-08-03 Crystalline forms of rufinamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2009A001412A IT1395736B1 (it) 2009-08-04 2009-08-04 Forme cristalline di rufinamide

Publications (2)

Publication Number Publication Date
ITMI20091412A1 ITMI20091412A1 (it) 2011-02-05
IT1395736B1 true IT1395736B1 (it) 2012-10-19

Family

ID=41566408

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2009A001412A IT1395736B1 (it) 2009-08-04 2009-08-04 Forme cristalline di rufinamide

Country Status (3)

Country Link
US (1) US20110034523A1 (it)
EP (1) EP2292609A1 (it)
IT (1) IT1395736B1 (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102219752B (zh) * 2011-04-21 2013-04-10 华润赛科药业有限责任公司 一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
PH22568A (en) 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
FR2819258B1 (fr) * 2001-01-11 2003-04-11 Essilor Int Procede d'obtention d'un latex photochromique stabilise, latex obtenu et application a l'optique ophtalmique
EP2230234B1 (en) * 2009-03-16 2012-11-28 Dipharma Francis S.r.l. Process for the preparation of rufinamide

Also Published As

Publication number Publication date
US20110034523A1 (en) 2011-02-10
ITMI20091412A1 (it) 2011-02-05
EP2292609A1 (en) 2011-03-09

Similar Documents

Publication Publication Date Title
HK1254977A1 (zh) 索非布韋(sofosbuvir)的結晶形式
LTPA2018008I1 (lt) Kristalai
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
SMT201600291B (it) Inibitori di proteasi hcv
SMT201600008B (it) Composti di piridazinone
DOP2012000114A (es) Inhibidor bromodominio de benzodiazepina
BRPI0915714A2 (pt) forma cristalina de posaconazol
DK2262793T3 (da) Krystallinske former af nilotinib-hci
IL216648A0 (en) Crystalline forms of febuxostat
HK1156306A1 (en) Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases hif--4-
BRPI1008744A2 (pt) hidrotratamento de caboidratos
SMT201600031B (it) Composti eterociclici di fenossimetile
BR112012005382A2 (pt) inibidores de jak
IT1392813B1 (it) Forme cristalline di dexlansoprazolo
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
SMT201500156B (it) Composti di diidropirrolonaftiridinione come inibitori di jak
DK2453858T3 (da) Fremgangsmåde
SMT201700085B (it) Forma cristallina di pemirolast
FR2952847B3 (fr) >
DK2425046T3 (da) Tæppe
IT1395736B1 (it) Forme cristalline di rufinamide
IT1394292B1 (it) Procedimento per la sintesi di pregabalina
TH105747B (th) รูปแบบผลึกของไนโตรเคทิคอล
IT1393671B1 (it) Composizione di inchiostro
UY33133A (es) Nuevos derivados de piridazina